Azitra (AZTR) News Today $0.46 0.00 (0.00%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartEarningsHeadlinesInsider TradesShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Promising Prospects for Azitra Inc: Buy Rating Supported by Advancements in ATR-12 and ATR-04 ProgramsNovember 15 at 7:32 PM | markets.businessinsider.comAzitra, Inc. Announces Q3 2024 Financial Results and Provides Business UpdatesNovember 12, 2024 | prnewswire.comAzitra, Inc.: Azitra to Present at BIO-Europe 2024October 30, 2024 | finanznachrichten.deAzitra to Participate in the 2024 Maxim Healthcare Virtual SummitOctober 11, 2024 | finance.yahoo.comStrong Buy Rating on Azitra Inc. for Promising Therapeutic Candidates in Oncology and Rare DiseasesSeptember 26, 2024 | markets.businessinsider.comAzitra, Inc. Announces Late-Breaking Presentation at the European Academy of Dermatology and Venereology CongressSeptember 24, 2024 | finance.yahoo.comBuy Rating Justified by Azitra Inc’s Advances in Rare Skin Disease Treatments and Financial StabilitySeptember 20, 2024 | markets.businessinsider.comAzitra Receives Fast Track Designation for ATR-04 for Skin Rash from EGFR InhibitorsSeptember 18, 2024 | finance.yahoo.comAzitra's ATR-04 Gets FDA Fast Track Designation For Skin Rash Linked To EGFR InhibitorsSeptember 18, 2024 | markets.businessinsider.comAzitra to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceSeptember 7, 2024 | finance.yahoo.comAzitra Announces First Patient Dosed in Phase 1b Trial of ATR-12 for Netherton SyndromeAugust 28, 2024 | finance.yahoo.comAzitra Inc (AZTR) Receives a Buy from Maxim GroupAugust 28, 2024 | markets.businessinsider.comAZTR: First ATR-12 Patient ScreenedAugust 24, 2024 | finance.yahoo.comAzitra Receives Study May Proceed letter from the FDA for IND to Treat Skin Rash from EGFR InhibitorsAugust 23, 2024 | finance.yahoo.comAzitra, Inc. (AZTR)August 21, 2024 | finance.yahoo.comAzitra Announces First Patient Screened and Scheduled to Enroll in Phase 1b Trial of ATR-12 for Netherton SyndromeAugust 21, 2024 | businesswire.comMcCarthy’s Buy Rating on Azitra Inc: Strong Pipeline and Strategic Financial PositioningAugust 16, 2024 | markets.businessinsider.comAZTR: Get Some Skin in the GameJuly 30, 2024 | msn.comCORRECTING and REPLACING Azitra, Inc. Announces Closing of $10.0 Million Public OfferingJuly 26, 2024 | finance.yahoo.comWhy Azitra Stock Is CrashingJuly 25, 2024 | benzinga.comWhy Is Azitra (AZTR) Stock Down 75% Today?July 24, 2024 | investorplace.comKSS Line Ltd. (044450.KS)July 24, 2024 | finance.yahoo.comWhy Azitra Stock Is Moving Higher On TuesdayJuly 23, 2024 | benzinga.comWhy Is Azitra (AZTR) Stock Up 315% Today?July 23, 2024 | investorplace.comAzitra, Inc. Strengthens Global Intellectual Property Portfolio with Newly Granted and Allowed PatentsJuly 23, 2024 | finance.yahoo.comAzitra, Inc. Announces Presentation at the 2024 BIO International ConventionMay 31, 2024 | businesswire.comAzitra reports progress on skin toxicity treatmentMay 19, 2024 | investing.comAzitra, Inc. Announces Positive Preclinical Data from ATR-04 Presented at the Society of Investigative Dermatology Annual MeetingMay 17, 2024 | businesswire.comOptimistic Outlook Justifies Buy Rating for Azitra Inc Amidst Promising Product Development and Strategic PartnershipsMay 11, 2024 | markets.businessinsider.comAzitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual MeetingMay 10, 2024 | businesswire.comAzitra, Inc. Announces Q1 2024 Financial Results and Provides Business UpdatesMay 9, 2024 | finance.yahoo.comAzitra, Inc. Announces New Preclinical Data to be Presented at the American Society of Gene and Cell Therapy MeetingApril 22, 2024 | businesswire.comAzitra, Inc. to Present New Data at Three Upcoming Scientific Conferences in May 2024April 18, 2024 | businesswire.comInsiders Are Buying These 11 Penny StocksApril 2, 2024 | finance.yahoo.comSilo Pharma And 3 Other Stocks Under $5 Insiders Are BuyingApril 2, 2024 | benzinga.comAzitra, Inc. Announces Full Year 2023 Financial Results and Provides Business UpdatesMarch 15, 2024 | businesswire.comAzitra, Inc. Announces Closing of Public OfferingFebruary 16, 2024 | finance.yahoo.comAzitra, Inc. Announces Closing of Public OfferingFebruary 16, 2024 | businesswire.comDow Edges Higher; QuidelOrtho Shares PlummetFebruary 14, 2024 | benzinga.comNasdaq Gains 100 Points; Kraft Heinz Sales Miss ViewsFebruary 14, 2024 | benzinga.comAzitra Prices Underwritten Public Offering Of 16.67 Mln Shares At $0.30/shr; Stock DropsFebruary 14, 2024 | nasdaq.comWhy Azitra (AZTR) Shares Are Down 67%February 14, 2024 | msn.comWhy Is Azitra (AZTR) Stock Down 70% Today?February 14, 2024 | investorplace.comWhy Is Azitra (AZTR) Stock Down 70% Today?February 14, 2024 | investorplace.comAzitra, Inc. Announces Pricing of Public OfferingFebruary 14, 2024 | finance.yahoo.comAzitra, Inc. Announces Pricing of Public OfferingFebruary 13, 2024 | businesswire.comS&P 500 Gains 1%; State Street Reports Upbeat EarningsJanuary 19, 2024 | benzinga.comABAT, PRQR and SHOT among mid-day moversJanuary 17, 2024 | msn.comAzitra, Inc. Strengthens Intellectual Property Portfolio with Newly Granted Patent in the USJanuary 16, 2024 | finance.yahoo.comAzitra GAAP EPS of -$0.16, revenue of $0.31MNovember 15, 2023 | msn.com Get Azitra News Delivered to You Automatically Sign up to receive the latest news and ratings for AZTR and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners… Claim your FREE 2024 Gold Guide AZTR Media Mentions By Week AZTR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AZTR News Sentiment▼1.270.54▲Average Medical News Sentiment AZTR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AZTR Articles This Week▼41▲AZTR Articles Average Week Get Azitra News Delivered to You Automatically Sign up to receive the latest news and ratings for AZTR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PHGE News IPA News NLSP News NRXP News TSBX News AWH News TLPH News HCWB News SNSE News INDP News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEAMERICAN:AZTR) was last updated on 11/16/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...True Gold Republic | SponsoredBuffett’s Selling Out: Is Your 401(k) About to Get Wiped Out?Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of...Golden Crest | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredWatch this before it gets removed If you missed it, my emergency election broadcast is now available - but will be removed soonPorter & Company | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredShocking footage from Bill Gates’ $100,000,000,000 AI BetIf you missed out on Nvidia, watch this BEFORE November 19th.Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Azitra, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Azitra With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
